🔗 Permalink

Assignee profile:

Cassiopea S.P.A.

City:

Lainate (MI)

Country:

Italy

Published Applications:

Last publication date:

2026-01-01

Patent Grants:

Last grant date:

2025-06-24

Top Inventors for applications by Cassiopea S.P.A.

These are the the leading inventors for applications assigned to Cassiopea S.P.A.:

Mauro AJANI 7 Lainate, Italy
Luigi Maria LONGO 6 Figino Serenza (CO), Italy
Luigi MORO 6 Cairate, Italy
Luigi Moro 5 Cairate (Milano), Italy

Luigi Maria Longo 4 Figino Serenza, Italy
Mauro AJANI 4 Lainate (MI), Italy
Luigi Moro 4 Cairate (VA), Italy
Luigi Moro 1 Milan, Italy

Giuseppe Celasco 1 Lainate (MI), Italy
Luigi Moro 1 Lainate (MI), Italy
Luigi Maria LONGO 1 Monza (MB), Italy

Recent patent applications by Cassiopea S.P.A.

Cassiopea S.P.A. based in Lainate (MI), IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-01

US20260000681A1

Human necessities

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

#2 | 2025-12-25

US20250387412A1

Human necessities

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

#3 | 2024-06-13

US20240189324A1

Human necessities

HIGH CONCENTRATION FORMULATION

#4 | 2023-04-06 ✅ Patent 12,337,002 granted on 2025-06-24

US20230104965A1

Human necessities

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

#5 | 2022-09-08 ✅ Patent 11,938,141 granted on 2024-03-26

US20220280531A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#6 | 2022-06-23 ✅ Patent 11,883,415 granted on 2024-01-30

US20220193093A1

Human necessities

High concentration formulation

#7 | 2020-07-16 ✅ Patent 11,213,531 granted on 2022-01-04

US20200222429A1

Human necessities

High concentration formulation

#8 | 2019-12-12 ✅ Patent 10,980,819 granted on 2021-04-20

US20190374553A1

Human necessities

High concentration formulation

#9 | 2019-09-19

US20190282589A1

Human necessities

HIGH CONCENTRATION FORMULATION

#10 | 2019-03-21 ✅ Patent 10,716,796 granted on 2020-07-21

US20190083511A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#11 | 2018-06-21 ✅ Patent 10,603,327 granted on 2020-03-31

US20180169113A1

Human necessities

High concentration formulation

#12 | 2016-11-10 ✅ Patent 10,166,245 granted on 2019-01-01

US20160326210A1

Chemistry; metallurgy

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#13 | 2016-11-10 ✅ Patent 10,159,682 granted on 2018-12-25

US20160324873A1

Human necessities

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#14 | 2016-10-20

US20160303141A1

Human necessities

CORTEXOLONE 17alpha-PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND/OR ATROPHIC SKIN DISORDERS

#15 | 2016-09-15 ✅ Patent 9,895,379 granted on 2018-02-20

US20160263127A1

Human necessities

17alpha, 21-dihydroxypregnene esters as antiandrogenic agents

#16 | 2015-08-06 ✅ Patent 9,211,295 granted on 2015-12-15

US20150216878A1

Human necessities

17 alpha, 21-dihydroxypregnene esters as antiandrogenic agents

Also check out Cassiopea S.P.A.'s (Lainate (MI), Italy) applicant profile with 4 patent applications submitted.

AssigneeID:

114451 ⎘